Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription

Articles published in
    September 2021
  1. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
    Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.
    >> Share

  2. GUO L, Yi X, Chen L, Zhang T, et al
    Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
    Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
    >> Share

    August 2021
  3. BALZORA S, May FP, Ogedegbe G
    COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
    Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.
    >> Share

  4. SU F
    COVID-19 and cirrhosis: a combination we must strive to prevent.
    Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
    >> Share

  5. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
    Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
    >> Share

  6. OLYNYK JK, Ramm GA
    Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
    >> Share

  7. TAI CS, Ni YH, Lee PI
    An Unusual Case with a Huge Hepatic Cystic Mass.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.
    >> Share

  8. CARRIQUE L, Quance J, Tan A, Abbey S, et al
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
    Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
    >> Share

    July 2021
  9. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
    Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
    >> Share

  10. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
    TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
    >> Share

  11. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    >> Share

  12. YE P, Miao H, Chen Y
    An unusual case of symptomatic portal hypertension.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
    >> Share

    June 2021
  13. VALENTI L, Mondelli M, Colombo M
    Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.
    >> Share

  14. LI H, Liu H
    Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
    Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
    >> Share

    May 2021
  15. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
    >> Share

  16. GARCIA-TSAO G, Abraldes JG
    Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
    >> Share

  17. PERRY IE, Azam MU, Yap JE
    Carcinoma Camouflage.
    Gastroenterology. 2021;160:1940-1942.
    >> Share

  18. SHEN C, Zong Z, Xu N
    "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
    Gastroenterology. 2021;160:e7-e9.
    >> Share

  19. NAYAK LJ, Sondhi AR, Westerhoff M
    Gastroenterology. 2021;160:e5-e6.
    >> Share

  20. HA NB, Wang CW, El-Nachef N
    An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
    Gastroenterology. 2021;160:e1-e4.
    >> Share

    April 2021
  21. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
    Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
    Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
    >> Share

  22. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
    >> Share

  23. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
    Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
    Gastroenterology. 2021;160:1891-1893.
    >> Share

  24. KHAN MU, Mushtaq K, Alkaabi SR
    Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
    Gastroenterology. 2021;160:1894-1895.
    >> Share

  25. VERMA N, Duseja A, Singh V
    Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
    Gastroenterology. 2021;160:1893-1894.
    >> Share

  26. LUUKKONEN PK, Salomaa V, Aberg F
    The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
    Gastroenterology. 2021;160:1874-1875.
    >> Share

  27. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
    Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
    Gastroenterology. 2021;160:1634-1646.
    >> Share

    March 2021
  28. PHAM DH, Kudira R, Xu L, Valencia CA, et al
    Deleterious variants in ABCC12 are detected in idiopathic chronic cholestasis and cause intrahepatic bile duct loss in model organisms: ABCC12 pathogenic variants lead to cholestasis.
    Gastroenterology. 2021 Mar 18. pii: S0016-5085(21)00535.
    >> Share

  29. LEE-ALLEN J, Shah BJ
    How to incorporate health equity training into Gastroenterology and Hepatology fellowship.
    Gastroenterology. 2021 Mar 15. pii: S0016-5085(21)00526.
    >> Share

  30. SINGAL AG, Hoshida Y, Pinato DJ, Marrero J, et al
    International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.
    Gastroenterology. 2021 Mar 8. pii: S0016-5085(21)00518.
    >> Share

  31. ADENIJI N, Carr RM, Aby ES, Catana AM, et al
    Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases.
    Gastroenterology. 2021;160:1406-1409.
    >> Share

  32. CASADEI-GARDINI A, Cascinu S, Colombo M
    Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
    Gastroenterology. 2021;160:1423-1424.
    >> Share

  33. GOLDBERG D, Ross-Driscoll K, Lynch R
    County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
    Gastroenterology. 2021;160:1140-1150.
    >> Share

  34. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
    The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Gastroenterology. 2021;160:1224-1239.
    >> Share

  35. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
    An Unsuspected Cause of Rectal Bleeding.
    Gastroenterology. 2021;160:e1-e2.
    >> Share

    February 2021
  36. LIU D, Wong CC, Zhou Y, Li C, et al
    Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase 3 and is a therapeutic target.
    Gastroenterology. 2021 Feb 26. pii: S0016-5085(21)00456.
    >> Share

  37. DUWAERTS CC, Le Guillou D, Her CL, Phillips NJ, et al
    iPSC-derived hepatocytes from patients with nonalcoholic fatty liver disease display a disease-specific gene expression profile.
    Gastroenterology. 2021 Feb 25. pii: S0016-5085(21)00455.
    >> Share

    Multiple Hepatic and Pulmonary Tumours Combined with Bilateral Adrenal Masses in a Young Female with von Hippel-Lindau Disease.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00421.
    >> Share

  39. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    >> Share

  40. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
    High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Gastroenterology. 2021;160:831-846.
    >> Share

  41. NASSANI N, Melitas C, Villa E
    An Unusual Cause of Watery Diarrhea.
    Gastroenterology. 2021;160:671-674.
    >> Share

    January 2021
    REPLY: Joseph Ahn, John I Allen, and Vijay H Shah Response to: The Path to Gastroenterology and Hepatology Leadership Inadvertently Perpetuating the Glass Ceiling and Sticky Floor.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00271.
    >> Share

  43. XU J, Kausalya PJ, Van Hul N, Caldez MJ, et al
    Protective functions of ZO-2/Tjp2 expressed in hepatocytes and cholangiocytes against liver injury and cholestasis.
    Gastroenterology. 2021 Jan 16. pii: S0016-5085(21)00094.
    >> Share

  44. CORLEY DA, Peek RM Jr, Simpson BA
    Paradigm-Shifting Research in Gastroenterology, Hepatology, and Nutrition: A Top 20 List of Articles Published in 2020.
    Gastroenterology. 2021 Jan 14. pii: S0016-5085(21)00087.
    >> Share

  45. MAHMUD N, Kaplan DE, Goldberg DS, Taddei TH, et al
    Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Non-Completion in the VHA Cohort During the COVID-19 Pandemic.
    Gastroenterology. 2021 Jan 9. pii: S0016-5085(21)00066.
    >> Share

  46. ACHARYA C, Bajaj JS
    Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
    Gastroenterology. 2021;160:556-572.
    >> Share

  47. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
    Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;160:193-205.
    >> Share

    December 2020
  48. VANWAGNER LB, Issaka RB
    The Path to Gastroenterology & Hepatology Leadership: Inadvertently Perpetuating the Glass Ceiling and Sticky Floor.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35610.
    >> Share

  49. JIN B, Wu XA, Du SD
    Human Pluripotent Stem Cell-derived Hepatic Organoids: A Promising Novel Model of Liver Diseases.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35595.
    >> Share

  50. MYOJIN Y, Hikita H, Sugiyama M, Sasaki Y, et al
    Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35551.
    >> Share

  51. EMDIN CA, Haas M, Ajmera V, Simon TG, et al
    Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study.
    Gastroenterology. 2020 Dec 10. pii: S0016-5085(20)35545.
    >> Share

  52. YOUNOSSI ZM, Anstee QM, Wai-Sun Wong V, Trauner M, et al
    The Association of Histologic and Non-invasive Tests with Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35529.
    >> Share

  53. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
    Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Gastroenterology. 2020;159:2232-2234.
    >> Share

    November 2020
  54. HSU SJ, Zhang C, Jeong J, Lee SI, et al
    Enhanced meningeal lymphatic drainage ameliorates neuroinflammation and hepatic encephalopathy in cirrhotic rats.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35439.
    >> Share

  55. LAU LHS, Wong SH, Yip TCF, Wong GLH, et al
    Collateral Effect of Coronavirus Disease 2019 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases: A Territory-wide Observational Study in Hong Kong.
    Gastroenterology. 2020;159:1979-1981.
    >> Share

  56. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
    Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Gastroenterology. 2020;159:1985-1987.
    >> Share

  57. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
    Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Gastroenterology. 2020;159:1731-1751.
    >> Share

  58. LANG S, Demir M, Martin A, Jiang L, et al
    Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;159:1839-1852.
    >> Share

    October 2020
  59. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
    Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
    >> Share

  60. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
    AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
    >> Share

  61. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    >> Share

  62. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    >> Share

  63. ROMEO S
    MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
    Gastroenterology. 2020;159:1231-1232.
    >> Share

  64. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
    Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
    Gastroenterology. 2020;159:1471-1486.
    >> Share

    September 2020
  65. HEINRICH B, Brown ZJ, Diggs LP, Vormehr M, et al
    Steatohepatitis Impairs T cell-directed Immunotherapies Against Liver Tumors in Mice.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35212.
    >> Share

  66. ROGAL SS, Powell BJ, Chinman M
    Moving towardsImpact: An Introduction to Implementation Science for Gastroenterologists and Hepatologists.
    Gastroenterology. 2020 Sep 17. pii: S0016-5085(20)35166.
    >> Share

  67. SOLE C, Guilly S, Da Silva K, Llopis M, et al
    Gastroenterology. 2020 Sep 14. pii: S0016-5085(20)35150.
    >> Share

  68. GUIDOTTI LG, La Vecchia C, Colombo M
    Is it time to recommend low-dose aspirin treatment for the prevention of hepatocellular carcinoma?
    Gastroenterology. 2020 Sep 9. pii: S0016-5085(20)35134.
    >> Share

  69. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
    ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Gastroenterology. 2020;159:929-943.
    >> Share

  70. CHAI C, Cox B, Yaish D, Gross D, et al
    Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Gastroenterology. 2020;159:999-1014.
    >> Share

  71. WANG Y, Pan Y, Zhou Z
    An Unusual Cause of Fever in a Man With a Liver Mass.
    Gastroenterology. 2020;159:842-844.
    >> Share

    August 2020
  72. MOLINA-SANCHEZ P, Ruiz de Galarreta M, Yao MA, Lindblad KE, et al
    Cooperation between distinct cancer driver genes underlies inter-tumor heterogeneity in hepatocellular carcinoma.
    Gastroenterology. 2020 Aug 16. pii: S0016-5085(20)35054.
    >> Share

  73. HARRISON SA, Neff G, Guy CD, Bashir MR, et al
    Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
    Gastroenterology. 2020 Aug 8. pii: S0016-5085(20)35018.
    >> Share

  74. FLEMMING JA, Mullin M, Lu J, Sarkar MA, et al
    Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study.
    Gastroenterology. 2020 Aug 8. pii: S0016-5085(20)35024.
    >> Share

  75. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    >> Share

  76. SINGH S, Khan A
    Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.
    Gastroenterology. 2020;159:768-771.
    >> Share

  77. PENG H, Fu YX
    The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular Carcinoma.
    Gastroenterology. 2020;159:434-436.
    >> Share

  78. ZOLLER H, Wagner S, Tilg H
    Is Heterozygosity for the Alpha-1 Antitrypsin Risk Allele Pi *MZ a Disease Modifier or Genetic Risk Factor?
    Gastroenterology. 2020;159:433-434.
    >> Share

  79. NABI O, Lacombe K, Boursier J, Mathurin P, et al
    Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Gastroenterology. 2020;159:791-793.
    >> Share

  80. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
    Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
    Gastroenterology. 2020;159:534-548.
    >> Share

  81. GUPTA V, Gupta I, Park J, Bram Y, et al
    Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
    Gastroenterology. 2020;159:624-638.
    >> Share

  82. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
    Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
    Gastroenterology. 2020;159:639-651.
    >> Share

    July 2020
  83. BAJAJ JS, Reddy KR, O'Leary JG, Vargas HE, et al
    Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute on Chronic Liver Failure and Death in Patients With Cirrhosis.
    Gastroenterology. 2020 Jul 17. pii: S0016-5085(20)34947.
    >> Share

  84. SULTAN S, Altayar O, Siddique SM, Davitkov P, et al
    AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.
    Gastroenterology. 2020;159:320-334.
    >> Share

  85. ARNOLD M, Abnet CC, Neale RE, Vignat J, et al
    Global Burden of 5 Major Types of Gastrointestinal Cancer.
    Gastroenterology. 2020;159:335-349.
    >> Share

  86. KOTHA S, Potts J, Thorburn D
    An Unusual Complication of a Cystic Liver Lesion.
    Gastroenterology. 2020;159:e9-e11.
    >> Share

    June 2020
  87. SKARET MM, Vicente DA, Deising AC
    An Enlarging Hepatic Mass of Unknown Etiology.
    Gastroenterology. 2020 Jun 26. pii: S0016-5085(20)34858.
    >> Share

  88. DASGUPTA D, Nakao Y, Mauer AS, Thompson JM, et al
    IRE1A Stimulates Hepatocyte-derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Gastroenterology. 2020 Jun 20. pii: S0016-5085(20)34831.
    >> Share

  89. LA VECCHIA C, Lotti M, Colombo M
    Asbestos exposure and increased risk of intrahepatic cholangiocarcinoma: enough to infer causality?
    Gastroenterology. 2020 Jun 19. pii: S0016-5085(20)34837.
    >> Share

  90. CHOPYK DM, Grakoui A
    Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Gastroenterology. 2020 Jun 19. pii: S0016-5085(20)34839.
    >> Share

  91. INNES H, Buch S, Hutchinson S, Guha IN, et al
    Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
    Gastroenterology. 2020 Jun 16. pii: S0016-5085(20)34767.
    >> Share

  92. LASSAILLY G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, et al
    Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34758.
    >> Share

  93. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    >> Share

  94. YIP TC, Wong GL
    Gastroenterology. 2020;158:2312-2313.
    >> Share

  95. ZHAO M, Zhao L, Xiong X, He Y, et al
    TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits gamma-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.
    Gastroenterology. 2020;158:2266-2281.
    >> Share

    May 2020
  96. DING X, He M, Chan AWH, Song QX, et al
    Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30659.
    >> Share

  97. HAJIFATHALIAN K, Krisko T, Mehta A, Kumar S, et al
    Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30602.
    >> Share

  98. KIM D, Konyn P, Cholankeril G, Wong RJ, et al
    Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30599.
    >> Share

  99. SANGHA M, Kelly CR, Rauschert L
    Liver and Gallbladder Herniation.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30279.
    >> Share

  100. MAHMUD N, Hubbard RA, Kaplan DE, Serper M, et al
    Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study.
    Gastroenterology. 2020 May 5. pii: S0016-5085(20)30597.
    >> Share

  101. TURATI F, La Vecchia C, Colombo M
    Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening?
    Gastroenterology. 2020;158:1838-1840.
    >> Share

  102. TAYLOR RS, Taylor RJ, Bayliss S, Hagstrom H, et al
    Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1611-1625.
    >> Share

  103. SCORLETTI E, Afolabi PR, Miles EA, Smith DE, et al
    Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;158:1597-1610.
    >> Share

  104. QIN WH, Yang ZS, Li M, Chen Y, et al
    High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
    Gastroenterology. 2020;158:1713-1727.
    >> Share

  105. MAHER JJ, Schattenberg JM
    Nonalcoholic Fatty Liver Disease in 2020.
    Gastroenterology. 2020;158:1849-1850.
    >> Share

  106. GOLDNER D, Lavine JE
    Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
    Gastroenterology. 2020;158:1967-1983.
    >> Share

  107. KRAWCZYK M, Liebe R, Lammert F
    Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.
    Gastroenterology. 2020;158:1865-1880.
    >> Share

  108. AZZU V, Vacca M, Virtue S, Allison M, et al
    Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;158:1899-1912.
    >> Share

  109. SARAN AR, Dave S, Zarrinpar A
    Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.
    Gastroenterology. 2020;158:1948-1966.
    >> Share

    Therapeutic Landscape for NAFLD in 2020.
    Gastroenterology. 2020;158:1984-1998.
    >> Share

  111. COTTER TG, Rinella M
    Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
    Gastroenterology. 2020;158:1851-1864.
    >> Share

  112. ARON-WISNEWSKY J, Warmbrunn MV, Nieuwdorp M, Clement K, et al
    Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
    Gastroenterology. 2020;158:1881-1898.
    >> Share

  113. SCHWABE RF, Tabas I, Pajvani UB
    Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2020;158:1913-1928.
    >> Share

  114. ESLAM M, Sanyal AJ, George J
    MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
    Gastroenterology. 2020;158:1999-2014.
    >> Share

    April 2020
  115. NOUREDDIN M, Chan JL, Barradas K, Dimick-Santos L, et al
    Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum.
    Gastroenterology. 2020 Apr 27. pii: S0016-5085(20)30556.
    >> Share

  116. PONTES AFECTO EM, Joao DA, Resende Rodrigues MA
    Unusual esophageal polyps in advanced cirrhosis.
    Gastroenterology. 2020 Apr 23. pii: S0016-5085(20)30559.
    >> Share

  117. GOTFRIED J, Naftali T, Schey R
    Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gastroenterology. 2020 Apr 22. pii: S0016-5085(20)30563.
    >> Share

  118. KRIETMAN K, Snell PD, Kothadia JP
    An Uncommon Cause of Hepatic Hematoma.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30508.
    >> Share

  119. CARVAO J, Pereira VM, Jasmins L
    A case of unexplained cutaneous lesions, cholestatic hepatitis and non-cirrhotic portal hypertension in a female patient.
    Gastroenterology. 2020 Apr 16. pii: S0016-5085(20)30494.
    >> Share

  120. KAMBOJ AK, Yung-Lun Chin J, Huebert RC
    A Curious Case of Confusion in a Patient with Cirrhosis.
    Gastroenterology. 2020 Apr 15. pii: S0016-5085(20)30513.
    >> Share

  121. KUNG-CHUN CHIU D, Wai-Hin Yuen V, Wing-Sum Cheu J, Wei LL, et al
    Hepatocellular Carcinoma Cells Upregulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Gastroenterology. 2020 Apr 7. pii: S0016-5085(20)30461.
    >> Share

  122. THEVENOT T, Charon-Barra C, Calame P
    Unusual Calcified Lesions of the Liver and Lung in a Young Woman.
    Gastroenterology. 2020;158:1222-1223.
    >> Share

  123. ZHANG Y, Shaikh N, Ferey JL, Wankhade UD, et al
    Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice.
    Gastroenterology. 2020;158:1402-1416.
    >> Share

    March 2020
  124. EL-SERAG HB, Kanwal F, Feng Z, Marrero JA, et al
    Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings from Texas Hepatocellular Carcinoma Consortium Cohort.
    Gastroenterology. 2020 Mar 29. pii: S0016-5085(20)30403.
    >> Share

    Channelopathy of the pancreas causes chronic pancreatitis.
    Gastroenterology. 2020 Mar 20. pii: S0016-5085(20)30376.
    >> Share

  126. KAMAL F, Khan MA
    Is tenofovir associated with lower risk of hepatocellular carcinoma in patients with chronic hepatitis B compared to entecavir?
    Gastroenterology. 2020 Mar 19. pii: S0016-5085(20)30373.
    >> Share

  127. LEE HA, Seo YS, Kim SU
    Risk of Hepatocellular Carcinoma with Tenofovir vs. Entecavir in Patients with Chronic Hepatitis B.
    Gastroenterology. 2020 Mar 19. pii: S0016-5085(20)30374.
    >> Share

  128. WANG F, Hou W, Chitsike L, Xu Y, et al
    ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Gastroenterology. 2020 Mar 11. pii: S0016-5085(20)30334.
    >> Share

  129. MEJIAS M, Gallego J, Naranjo-Suarez S, Ramirez M, et al
    CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30328.
    >> Share

  130. KRUGER AJ
    Can macrophages in cirrhotic ascites fluid predict clinical outcome in SBP?
    Gastroenterology. 2020 Mar 2. pii: S0016-5085(20)30267.
    >> Share

  131. LIU P, Liang B, Liu M, Lebbink JHG, et al
    Oncogenic Mutations in Armadillo Repeats 5 and 6 of beta-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes.
    Gastroenterology. 2020;158:1029-1043.
    >> Share

    February 2020
  132. HOWELL DJ, Chan HL, Feld JJ, Hellard ME, et al
    Closing the stable door after the horse has bolted - should we be treating people with immune-tolerant chronic hepatitis B to prevent hepatocellular carcinoma?
    Gastroenterology. 2020 Feb 20. pii: S0016-5085(20)30238.
    >> Share

  133. GEHRKE N, Schattenberg JM
    Metabolic inflammation - a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30230.
    >> Share

  134. LI D, Li N, Zhang YF, Fu H, et al
    Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.
    Gastroenterology. 2020 Feb 11. pii: S0016-5085(20)30211.
    >> Share

  135. ESHKENAZY R, Inbal Y, Azoulay D
    A New Cause of Cholangitis Following Roux-en-Y Hepaticojejunostomy.
    Gastroenterology. 2020 Feb 1. pii: S0016-5085(20)30130.
    >> Share

  136. BIECHELE J, Fox M
    A Patient with Metastatic Lung Cancer and Dysphagia.
    Gastroenterology. 2020;158:485-487.
    >> Share

    January 2020
  137. LOOMBA R, Lim JK, Patton H, El-Serag HB, et al
    AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2020 Jan 29. pii: S0016-5085(20)30127.
    >> Share

  138. STENGEL S, Quickert S, Lutz P, Ibidapo-Obe O, et al
    Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis.
    Gastroenterology. 2020 Jan 23. pii: S0016-5085(20)30121.
    >> Share

  139. LIN YH, Zhang S, Zhu M, Lu T, et al
    Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity but Develop Fewer Tumors Following Chronic Liver Injury.
    Gastroenterology. 2020 Jan 20. pii: S0016-5085(20)30116.
    >> Share

  140. LIU X, Xu J, Rosenthal S, Zhang LJ, et al
    Identification of Lineage-specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
    Gastroenterology. 2020 Jan 20. pii: S0016-5085(20)30117.
    >> Share

  141. SHIELS MS, O'Brien TR
    Recent Decline in Hepatocellular Carcinoma Rates in the United States.
    Gastroenterology. 2020 Jan 18. pii: S0016-5085(20)30010.
    >> Share

  142. LO GH
    Did direct-acting antiviral therapy for hepatitis C virus infection really improve the survival of patients with hepatocellular carcinoma ?
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30102.
    >> Share

  143. YOUNOSSI ZM, Henry L
    Are Noninvasive Scoring Systems for Persons With Chronic Liver Disease Ready for Prime Time?
    Gastroenterology. 2020;158:40-42.
    >> Share

  144. VERHELST X, Dias AM, Colombel JF, Vermeire S, et al
    Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases.
    Gastroenterology. 2020;158:95-110.
    >> Share

  145. HAGSTROM H, Talback M, Andreasson A, Walldius G, et al
    Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.
    Gastroenterology. 2020;158:200-214.
    >> Share

  146. QUACH B, Han S, Attwell A
    Septic Shock After Travel to Rural Africa.
    Gastroenterology. 2020;158:56-57.
    >> Share

  147. YANAI M, Yamamoto A, Itou S
    Multiple Low-Density Areas in the Liver.
    Gastroenterology. 2020;158:e7-e8.
    >> Share

  148. DONG ZR, Zhi XT, Li T
    A Rapidly Progressing Polycystic Liver Disease?
    Gastroenterology. 2020;158:e9-e11.
    >> Share

    December 2019
  149. CHALASANI N, Abdelmalek MF, Garcia-Tsao G, Vuppalanchi R, et al
    Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension.
    Gastroenterology. 2019 Dec 5. pii: S0016-5085(19)41895.
    >> Share

  150. LIU T, Shyh-Chang N
    Oncofetal SALL4-Driven Tumorigenesis Is Highly Dependent on Oxidative Phosphorylation, Revealing Therapeutic Opportunities.
    Gastroenterology. 2019;157:1475-1477.
    >> Share

  151. GURM H, Jamorabo DS, Mohanty SR
    Weight Loss and Granulomatous Liver Disease.
    Gastroenterology. 2019;157:e3-e5.
    >> Share

  152. VOS MB, Dimick-Santos L, Mehta R, Omokaro SO, et al
    Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;157:1448-1456.
    >> Share

  153. TAN JL, Li F, Yeo JZ, Yong KJ, et al
    New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
    Gastroenterology. 2019;157:1615-1629.
    >> Share

    November 2019
  154. LAMPERTICO P, Papatheodoridis GV
    Gastroenterology. 2019 Nov 7. pii: S0016-5085(19)41524.
    >> Share

  155. SHEN T, Mao Y, Chen C
    Gastroenterology. 2019;157:1439-1440.
    >> Share

  156. DEVARBHAVI H, Bjornsson ES
    RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Gastroenterology. 2019;157:1437-1438.
    >> Share

  157. CONG W, Xin Q, Gao Y
    RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Gastroenterology. 2019;157:1438-1439.
    >> Share

  158. YANG M, Li Z, Dou D
    Can Retrospective Studies Confirm Causes of Drug-Induced Liver Injury?
    Gastroenterology. 2019;157:1436-1437.
    >> Share

  159. BAJAJ JS, Sharma A, Dudeja PK
    Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans.
    Gastroenterology. 2019;157:1180-1183.
    >> Share

  160. GHABRIL M, Gu J, Yoder L, Corbito L, et al
    Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.
    Gastroenterology. 2019;157:1245-1252.
    >> Share

    October 2019
  161. XIANG J, Zhang N, Sun H, Su L, et al
    Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of PD-L1 in Hepatocellular Carcinoma Cells.
    Gastroenterology. 2019 Oct 30. pii: S0016-5085(19)41477.
    >> Share

  162. CARUSO S, Nault JC
    A dive into the deep heterogeneity of hepatocellular carcinoma.
    Gastroenterology. 2019 Oct 10. pii: S0016-5085(19)41420.
    >> Share

  163. LE BERRE C, Sandborn WJ, Aridhi S, Devignes MD, et al
    Application of Artificial Intelligence to Gastroenterology and Hepatology.
    Gastroenterology. 2019 Oct 5. pii: S0016-5085(19)41412.
    >> Share

  164. SUNDARAM V, Jalan R
    Gastroenterology. 2019;157:1163-1164.
    >> Share

  165. WRIGHT GEB, Drogemoller BI, Ross CJD, Carleton BC, et al
    Genome-Wide Association Studies of Drug-Induced Liver Injury Make Progress Beyond the HLA Region.
    Gastroenterology. 2019;157:1167-1168.
    >> Share

  166. CHOUDHARY NS, Saraf N, Saigal S, Soin AS, et al
    Factors Associated With Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: Unanswered Questions.
    Gastroenterology. 2019;157:1162-1163.
    >> Share

    September 2019
  167. CHEUK-FUNG YIP T, Wai-Sun Wong V, Lik-Yuen Chan H, Tse YK, et al
    Tenofovir is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.
    Gastroenterology. 2019 Sep 28. pii: S0016-5085(19)41367.
    >> Share

  168. TRIPATHI A, Paspulati R, Cohen SM
    Dyspnea in Hepatocellular Carcinoma.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41355.
    >> Share

  169. DING X, He M, Chan AWH, Song QX, et al
    Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41338.
    >> Share

  170. SINGAL AG
    Gastroenterology. 2019;157:901-902.
    >> Share

  171. BAJAJ JS, Gillevet PM
    Gastroenterology. 2019;157:902-903.
    >> Share

  172. KHALILI K
    Historical Data Are Not Relevant to the Diagnostic Performance of Ultrasound in Surveillance for Hepatocellular Carcinoma.
    Gastroenterology. 2019;157:899-900.
    >> Share

  173. NAYAK LJ, Sondhi AR, Westerhoff M
    A Rare Complication of a Rare Disease.
    Gastroenterology. 2019;157:616-618.
    >> Share

  174. ESLAM M, Sanyal AJ, George J
    Toward More Accurate Nomenclature for Fatty Liver Diseases.
    Gastroenterology. 2019;157:590-593.
    >> Share

  175. HAMESCH K, Mandorfer M, Pereira VM, Moeller LS, et al
    Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
    Gastroenterology. 2019;157:705-719.
    >> Share

    August 2019
  176. TSENG TC, Liu CJ, Hsu CY, Hong CM, et al
    High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41248.
    >> Share

  177. TAO H, Chen X
    The role of CXCR6 deficient Natural Killer T- and CD4 + T cells in hepatocarcinogenesis.
    Gastroenterology. 2019 Aug 7. pii: S0016-5085(19)41194.
    >> Share

  178. TEMMERMAN F, Nevens F
    Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story.
    Gastroenterology. 2019;157:298-299.
    >> Share

  179. TORRES S, Baulies A, Insausti-Urkia N, Alarcon-Vila C, et al
    Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver Failure.
    Gastroenterology. 2019;157:552-568.
    >> Share

  180. VAN AERTS RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, et al
    Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
    Gastroenterology. 2019;157:481-491.
    >> Share

  181. XIAO X, Chen L, Wu H
    Liver Masses.
    Gastroenterology. 2019;157:e3-e4.
    >> Share

  182. ZHUANG BW, Wang W, Xie XY
    A Rare Case of Liver Tumor.
    Gastroenterology. 2019;157:e5-e7.
    >> Share

  183. SHAH-KHAN SM, Hsueh W, Reynolds GJ
    An 8-Year History of Increased Level of Aspartate Aminotransferase.
    Gastroenterology. 2019;157:318-319.
    >> Share

    July 2019
  184. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma.
    Gastroenterology. 2019 Jul 30. pii: S0016-5085(19)41137.
    >> Share

  185. FAN W, Liu T, Chen W, Hammad S, et al
    ECM1 Prevents Activation of Transforming Growth Factor beta, Hepatic Stellate Cells, and Fibrogenesis in Mice.
    Gastroenterology. 2019 Jul 27. pii: S0016-5085(19)41133.
    >> Share

  186. IOANNOU GN, Beste LA, Green PK, Singal AG, et al
    Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores.
    Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41130.
    >> Share

  187. MORAN-SALVADOR E, Garcia-Macia M, Sivaharan A, Sabater L, et al
    Fibrogenic Activity of MECP2 is Regulated by Phosphorylation in Hepatic Stellate Cells.
    Gastroenterology. 2019 Jul 25. pii: S0016-5085(19)41126.
    >> Share

  188. MOEINI A, Torrecilla S, Tovar V, Montironi C, et al
    An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Gastroenterology. 2019 Jul 22. pii: S0016-5085(19)41121.
    >> Share

  189. PANEL M, Isaac Ruiz, Rozenn Brillet, Lafdil F, et al
    Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia-reperfusion injury.
    Gastroenterology. 2019 Jul 20. pii: S0016-5085(19)41119.
    >> Share

  190. LO GH
    The transplantation of fecal microbiota for cirrhotic patients.
    Gastroenterology. 2019 Jul 12. pii: S0016-5085(19)41090.
    >> Share

  191. JAIN A, Scavo L, Cross D, Petney M, et al
    PeriLeve: An Implantable Peritoneovesicular Biopowered Shunt to Manage Patients with Refractory Ascites.
    Gastroenterology. 2019;157:21-22.
    >> Share

    June 2019
  192. SCHWIMMER JB, Johnson JS, Angeles JE, Behling C, et al
    Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019 Jun 27. pii: S0016-5085(19)41037.
    >> Share

  193. GOUGELET A, Sartor C, Senni N, Calderaro J, et al
    Hepatocellular Carcinomas With Mutational Activation of Beta Catenin Require Choline and can be Detected by Positron Emission Tomography.
    Gastroenterology. 2019 Jun 10. pii: S0016-5085(19)40988.
    >> Share

  194. YAN J, Tung HC, Li S, Niu Y, et al
    Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
    Gastroenterology. 2019 Jun 3. pii: S0016-5085(19)40984.
    >> Share

  195. MORO A, Okubo K, Sasaki K
    Goodbye for Good: Stepping Away From Recurrence.
    Gastroenterology. 2019;156:2353-2354.
    >> Share

  196. SHEN T, Liu Y, Shang J, Xie Q, et al
    Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Gastroenterology. 2019;156:2230-2241.
    >> Share

  197. HSU YC, Huang WH
    Abdominal Semicircular Calcified Lesion in a Febrile Woman.
    Gastroenterology. 2019;156:e7-e8.
    >> Share

    May 2019
  198. WIDJAJA AA, Singh BK, Adami E, Viswanathan S, et al
    Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.
    Gastroenterology. 2019 May 8. pii: S0016-5085(19)40858.
    >> Share

  199. CARUSO S, Calatayud AL, Pilet J, La Bella T, et al
    Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
    Gastroenterology. 2019 May 4. pii: S0016-5085(19)36771.
    >> Share

  200. AGRAWAL R, Majeed M, Gandhi S
    An unusual cause of esophageal varices.
    Gastroenterology. 2019 May 4. pii: S0016-5085(19)36770.
    >> Share

  201. BHAN I, Aryee M, Ting DT
    Gastroenterology. 2019;156:1933-1934.
    >> Share

  202. WANG J, Dong R, Zheng S
    Circulating Epithelial Cells in Patients With Liver Disease.
    Gastroenterology. 2019;156:1932.
    >> Share

  203. ROOS FJM, IJzermans JNM, van der Laan LJW
    Reply to "Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies from Patients with Liver Disease": Implications for Transplant Chimerism.
    Gastroenterology. 2019;156:1932-1933.
    >> Share

  204. HADDAD FG, Mulrooney S
    A Shiny Liver!
    Gastroenterology. 2019;156:1580-1581.
    >> Share

  205. LI H, Li CW, Li X, Ding Q, et al
    MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.
    Gastroenterology. 2019;156:1849-1861.
    >> Share

  206. EDDOWES PJ, Sasso M, Allison M, Tsochatzis E, et al
    Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1717-1730.
    >> Share

  207. CIRULLI ET, Nicoletti P, Abramson K, Andrade RJ, et al
    A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
    Gastroenterology. 2019;156:1707-1716.
    >> Share

    April 2019
  208. KIM HP, Moon AM, Dellon ES
    Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients with Varices: You Have Some Ex-Spleening to Do.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36721.
    >> Share

  209. LOHMANN V, Bartenschlager R
    Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36726.
    >> Share

  210. KIM SB, Kim JW, Choi JH
    A rare cause of multiple hepatic masses.
    Gastroenterology. 2019 Apr 14. pii: S0016-5085(19)35696.
    >> Share

  211. O'LEARY JG, Greenberg CS, Patton HM, Caldwell SH, et al
    Coagulation in Cirrhosis.
    Gastroenterology. 2019 Apr 12. pii: S0016-5085(19)35694.
    >> Share

  212. CASTERA L, Friedrich-Rust M, Loomba R
    Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1264-1281.
    >> Share

  213. CAI M, Kabir T, Jeyaraj PR
    A Curious Case of Refractory Hematochezia.
    Gastroenterology. 2019;156:e12-e13.
    >> Share

  214. SUNDARAM V, Jalan R, Wu T, Volk ML, et al
    Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Gastroenterology. 2019;156:1381-1391.
    >> Share

    March 2019
  215. FRANSES JW, Zhu AX
    Has PD-1 MET its match in hepatocellular carcinoma?
    Gastroenterology. 2019 Mar 26. pii: S0016-5085(19)34585.
    >> Share

  216. NAULT JC, Nahon P
    Direct Antiviral Agents and the Risk of Recurrence of Hepatocellular Carcinoma: Moving on?
    Gastroenterology. 2019 Mar 26. pii: S0016-5085(19)34583.
    >> Share

  217. FERNANDEZ J, Claria J, Amoros A, Aguilar F, et al
    Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
    Gastroenterology. 2019 Mar 21. pii: S0016-5085(19)33576.
    >> Share

  218. LOMBARDI A, Mondelli MU, Bruno R
    RE: Effects of long-term norfloxacin therapy in patients with advanced cirrhosis.
    Gastroenterology. 2019 Mar 14. pii: S0016-5085(19)33560.
    >> Share

  219. RAYAR M, Bardou-Jacquet E
    Recurrence of primary biliary cholangitis after liver transplantation: Is Tacrolimus really worse than other drugs?
    Gastroenterology. 2019 Mar 14. pii: S0016-5085(19)33562.
    >> Share

  220. SINGAL AG, Lim JK, Kanwal F
    AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2019 Mar 13. pii: S0016-5085(19)33558.
    >> Share

  221. HILSCHER MB, Sehrawat T, Arab Verdugo JP, Zeng Z, et al
    Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension.
    Gastroenterology. 2019 Mar 11. pii: S0016-5085(19)33554.
    >> Share

  222. ARROYO V
    Acute-On-Chronic Liver Failure in Cirrhosis Requires Expedited Decision for Liver Transplantation.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32514.
    >> Share

  223. MARQUARDT P, Hoshida Y, Singal AG
    Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32516.
    >> Share

  224. MOON AM, Weiss NS, Beste LA, Su F, et al
    Gastroenterology. 2019;156:1218-1220.
    >> Share

  225. VALOBRA T, Ceratti U, Gandino A
    Abdominal Septic Shock: An Eye-Popping Case.
    Gastroenterology. 2019;156:881-882.
    >> Share

    February 2019
  226. CHEN CY, Wang YP, Lu CL
    An Unusual Hepatic Mass in a Young Man.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32489.
    >> Share

  227. RAVINDRANATH A, Sarma MS, Yachha SK
    An elusive diagnosis in a child with fever and hepatomegaly.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32492.
    >> Share

  228. BRUIX J, Ayuso C
    Diagnosis of Hepatic Nodules in Patients at Risk for Hepatocellular Carcinoma: LI-RADS Probability Versus Certainty.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30381.
    >> Share

    The Changing Scenario of Screening and Surveillance of Esophageal Varices.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30384.
    >> Share

  230. INTAGLIATA NM, Caldwell SH, Tripodi A
    Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
    Gastroenterology. 2019 Feb 13. pii: S0016-5085(19)30372.
    >> Share

  231. THABUT D, Bureau C, Layese R, Bourcier V, et al
    Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(18)35303.
    >> Share

  232. TEUFEL M, Seidel H, Kochert K, Meinhardt G, et al
    Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma.
    Gastroenterology. 2019 Feb 6. pii: S0016-5085(19)30361.
    >> Share

    What Did We Learn From the ADAPT Trials?
    Gastroenterology. 2019;156:824-825.
    >> Share

    January 2019
  234. TAN AT, Yang N, Krishnamoorthy TL, Oei V, et al
    Use of Expression Profiles of HBV DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
    Gastroenterology. 2019 Jan 31. pii: S0016-5085(19)30348.
    >> Share

  235. WEI Y, Lao XM, Xiao X, Wang XY, et al
    Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Gastroenterology. 2019 Jan 31. pii: S0016-5085(19)30347.
    >> Share

  236. MOSSANEN JC, Kohlhepp M, Wehr A, Krenkel O, et al
    CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T and CD4+ T cell-Dependent Control of Senescence.
    Gastroenterology. 2019 Jan 30. pii: S0016-5085(19)30342.
    >> Share

  237. GRINDHEIM JM, Nicetto D, Donahue G, Zaret KS, et al
    PRC2 proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Gene Expression at Promoter Regions in Euchromatin in Mice.
    Gastroenterology. 2019 Jan 25. pii: S0016-5085(19)30104.
    >> Share

  238. BAJAJ JS, Fagan A, Gavis EA, Kassam Z, et al
    Long-term Outcomes after Fecal Microbiota Transplant in Cirrhosis.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30093.
    >> Share

  239. MULLANY K, Arbuckle S, Mei-Ling Siew S
    A Rare Cause of Neonatal Cholestasis without Liver Dysfunction.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30091.
    >> Share

  240. LAI JC, Rahimi R, Verna EC, Kappus MR, et al
    Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30058.
    >> Share

  241. KAPLAN DE, Serper M, Mehta R, Fox R, et al
    Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30053.
    >> Share

  242. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30057.
    >> Share

  243. CHATURANTABUT S, Shwartz A, Evason KJ, Cox AG, et al
    Estrogen Activation of G protein-coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.
    Gastroenterology. 2019 Jan 11. pii: S0016-5085(19)30031.
    >> Share

  244. KO S, Russell JO, Tian J, Gao C, et al
    Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.
    Gastroenterology. 2019;156:187-202.
    >> Share

    December 2018
  245. LIANG TJ, Terrault N
    Viral Hepatitis and Hepatocellular Carcinoma.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35423.
    >> Share

  246. PIANO S, Singh V, Caraceni P, Maiwall R, et al
    Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Gastroenterology. 2018 Dec 12. pii: S0016-5085(18)35402.
    >> Share

  247. SINGAL AG, Murphy CC
    Hepatocellular Carcinoma Surveillance: An effective but complex process.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35393.
    >> Share

  248. MAJEED A, Roberts SK, Kemp W
    RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35391.
    >> Share

  249. MEHTA N, Monto A, Yao FY
    Screening for hepatocellular carcinoma to improve cancer-related mortality: Looking behind when we should be looking ahead.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35392.
    >> Share

    Screening For Hepatocellular Carcinoma In Cirrhosis: Challenges And Unresolved Issues.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35390.
    >> Share

  251. MAHER JJ
    Macrophages Steal STING From the Infectious Disease Playbook to Promote Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:1687-1688.
    >> Share

  252. BHAN I, Mosesso K, Goyal L, Philipp J, et al
    Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease.
    Gastroenterology. 2018;155:2016-2018.
    >> Share

  253. BLACK DD, Gupta SK
    Gastrointestinal Complications and Management of Obesity.
    Gastroenterology. 2018;155:1655-1658.
    >> Share

    November 2018
  254. COSTENTIN CE, Layese R, Roudot-Thoraval F, Audureau E, et al
    Hepatocellular carcinoma screening: seeking a reasonable pathway to move forwards... In reply to "Hepatocellular carcinoma screening: seeking robust evidence" LTE 18-01689.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35294.
    >> Share

  255. SKEF W, Xia Y, Staudacher JJ, Jung B, et al
    Beyond Hospital Rankings: How Do We Measure Academic Strength in Gastroenterology/Hepatology Divisions?
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35289.
    >> Share

  256. POLISHCHUK EV, Merolla A, Lichtmannegger J, Romano A, et al
    Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis.
    Gastroenterology. 2018 Nov 16. pii: S0016-5085(18)35280.
    >> Share

  257. VAN DER POL CB, Lim CS, Sirlin CB, McGrath TA, et al
    Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35262.
    >> Share

  258. LIM U, Monroe KR, Buchthal S, Fan B, et al
    Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35263.
    >> Share

  259. ELSSNER C, Goeppert B, Longerich T, Scherr AL, et al
    Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35260.
    >> Share

  260. SANTOS PM, Butterfield LH
    Next Steps for Immune Checkpoints in Hepatocellular Carcinoma.
    Gastroenterology. 2018 Nov 9. pii: S0016-5085(18)35218.
    >> Share

  261. DHANASEKARAN R, Nault JC, Roberts LR, Zucman-Rossi J, et al
    Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.
    Gastroenterology. 2018 Nov 4. pii: S0016-5085(18)35210.
    >> Share

  262. PRIVITERA G, Figorilli F, Jalan R, Mehta G, et al
    Portosystemic Shunt Embolization and Recurrent Ascites: A Single-Center Case Series.
    Gastroenterology. 2018;155:1649-1650.
    >> Share

    October 2018
  263. KULIK L, El-Serag HB
    Epidemiology and Management of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35165.
    >> Share

    Hepatocellular carcinoma screening: seeking robust evidence ....
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35148.
    >> Share

  265. PEERY AF, Crockett SD, Murphy CC, Lund JL, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35147.
    >> Share

  266. MEHAL WZ
    Acetyl-Coenzyme A carboxylase inhibition in Nonalcoholic Steatohepatitis: Delivering as Anticipated.
    Gastroenterology. 2018 Oct 8. pii: S0016-5085(18)35103.
    >> Share

  267. MONTANO-LOZA AJ, Hansen BE, Corpechot C, Roccarina D, et al
    Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
    Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35089.
    >> Share

  268. GRETEN TF, Lai CW, Li G, Staveley-O'Carroll KF, et al
    Targeted and Immune-based Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35082.
    >> Share

  269. YANG XM, Cao XY, He P, Li J, et al
    Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Gastroenterology. 2018;155:1233-1249.
    >> Share

  270. SIVARAJAH SS, Shahzard S, Chew MH
    Unusual Cause of Liver Abscess.
    Gastroenterology. 2018;155:e7-e8.
    >> Share

    September 2018
  271. ZHAI ZZ, Wang L, Zuo XL
    A Rare Cause of Gastrointestinal Bleeding in a Patient With a History of Alcoholic Cirrhosis.
    Gastroenterology. 2018 Sep 18. pii: S0016-5085(18)35021.
    >> Share

  272. ZHANG XP, Wang K, Cheng SQ
    Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34774.
    >> Share

  273. LOOMBA R, Sanyal AJ, Kowdley KV, Terrault N, et al
    Factors Associated with Histologic Response in Adult Patients with Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34977.
    >> Share

  274. LUO X, Li H, Ma L, Zhou J, et al
    Expression of STING Is Increased in Liver Tissues from Patients With NAFLD and Promotes Macrophage-mediated Hepatic Inflammation and Fibrosis in Mice.
    Gastroenterology. 2018 Sep 10. pii: S0016-5085(18)34959.
    >> Share

  275. COOPER GS
    Should We Abandon Current Hepatocellular Carcinoma Screening Practices?
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34934.
    >> Share

  276. EL-SERAG HB
    Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels.
    Gastroenterology. 2018;155:607-609.
    >> Share

  277. MANSOURI A, Gattolliat CH, Asselah T
    Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.
    Gastroenterology. 2018;155:629-647.
    >> Share

  278. ASRANI SK, Kouznetsova M, Ogola G, Taylor T, et al
    Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013.
    Gastroenterology. 2018;155:719-729.
    >> Share

  279. CHAO X, Wang S, Zhao K, Li Y, et al
    Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
    Gastroenterology. 2018;155:865-879.
    >> Share

  280. TERRAULT N, Chen YC, Izumi N, Kayali Z, et al
    Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
    Gastroenterology. 2018;155:705-718.
    >> Share

    August 2018
  281. ROY S, Hooiveld GJ, Seehawer M, Caruso S, et al
    microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-associated Protein 1 to Suppress Hepatocarcinogenesis.
    Gastroenterology. 2018 Aug 27. pii: S0016-5085(18)34918.
    >> Share

  282. KIM HD, Song GW, Park S, Jung MK, et al
    Association Between Expression Level of PD1 by Tumor-Infiltrating CD8(+) T Cells and Features of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Aug 23. pii: S0016-5085(18)34897.
    >> Share

  283. KANWAL F, Kramer JR, Mapakshi S, Natarajan Y, et al
    Risk of Hepatocellular Cancer in Patients with Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34889.
    >> Share

  284. MOREAU R, Elkrief L, Bureau C, Perarnau JM, et al
    Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34891.
    >> Share

  285. BOYER A, Park SB, de Boer Y, Li Q, et al
    TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34892.
    >> Share

  286. KLEBER G, Sauerbruch T
    Concomitant gastric varices: Bleeding risk sign in patients with liver cirrhosis and esophageal varices?
    Gastroenterology. 2018 Aug 21. pii: S0016-5085(18)34879.
    >> Share

  287. THEVENOT T, Weil D, Di Martino V
    What is the true relationship between spontaneous portosystemic shunts and portopulmonary hypertension in cirrhotic patients?
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34878.
    >> Share

  288. EVERS L, Patel D, Porayko M
    An Unusual Cause of a Liver Mass in a Woman.
    Gastroenterology. 2018;155:e17-e18.
    >> Share

  289. SCHREINER P, Puippe G, Gubler C
    An Unusual, But Potentially Life-Threatening Lesion in the Cecum.
    Gastroenterology. 2018;155:e9-e10.
    >> Share

  290. LOW IW, John Harley HA, Clouston A
    Polycythemia Rubra Vera: Where Does the Truth Lie?
    Gastroenterology. 2018;155:e7-e8.
    >> Share

  291. KAILA V, Lager D, Jain R
    A Rare Tumor Presenting as a Rectal Mass.
    Gastroenterology. 2018;155:273-275.
    >> Share

  292. CHIEN MM, Wu JF, Lin MT
    An Unusual Cause of Cyanosis in a Child.
    Gastroenterology. 2018;155:e5-e6.
    >> Share

  293. VILAR-GOMEZ E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, et al
    Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Gastroenterology. 2018;155:443-457.
    >> Share

  294. AJMERA V, Park CC, Caussy C, Singh S, et al
    Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:307-310.
    >> Share

    July 2018
  295. LOOMBA R, Kayali Z, Noureddin M, Ruane P, et al
    GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients with Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Jul 27. pii: S0016-5085(18)34815.
    >> Share

  296. TRIPATHI DM, Vilaseca M, Lafoz E, Garcia-Caldero H, et al
    Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Gastroenterology. 2018 Jul 25. pii: S0016-5085(18)34810.
    >> Share

  297. WILDMAN-TOBRINER B, Middleton MM, Moylan CA, Rossi S, et al
    Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Jul 19. pii: S0016-5085(18)34784.
    >> Share

  298. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    >> Share

  299. HARRISON SA, Abdelmalek MF, Caldwell S, Shiffman ML, et al
    Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Jul 7. pii: S0016-5085(18)34758.
    >> Share

  300. MOON AM, Weiss NS, Beste LA, Su F, et al
    No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Jul 5. pii: S0016-5085(18)34721.
    >> Share

  301. SETHI V, Kurtom S, Tarique M, Lavania S, et al
    Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
    Gastroenterology. 2018;155:33-37.
    >> Share

  302. MA J, Hennein R, Liu C, Long MT, et al
    Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:107-117.
    >> Share

  303. HARRYVAN TJ, Tushuizen ME
    A Young Patient With Diabetes and Liver Tumors.
    Gastroenterology. 2018;155:25-26.
    >> Share

  304. ASHHAB AA, Singh D, Debes JD
    A Rare Cause of a Left Abdominal Liver Mass.
    Gastroenterology. 2018;155:e12-e13.
    >> Share

  305. WENDT S, Lubbert C, Karlas T
    An Emerging Cause for Liver Abscesses With Poor Prognosis.
    Gastroenterology. 2018;155:e18-e19.
    >> Share

  306. JIANG ZG, Vardeh H, Evenson A
    A Case of Cryptogenic Liver Failure.
    Gastroenterology. 2018;155:23-24.
    >> Share

  307. SAFFIOTI F, Mookerjee RP
    When Going With the Flow Sends You Upstream.
    Gastroenterology. 2018;155:21-22.
    >> Share

    June 2018
  308. PRADHAN-SUNDD T, Vats R, Russell JM, Singh S, et al
    Dysregulated bile transporters and impaired tight junctions during chronic liver injury in mice.
    Gastroenterology. 2018 Jun 28. pii: S0016-5085(18)34690.
    >> Share

  309. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    >> Share

  310. MUSSO G, Cassader M, Paschetta E, Gambino R, et al
    Bioactive lipid species and metabolic pathways in progression and resolution of Non-Alcoholic Steatohepatitis.
    Gastroenterology. 2018 Jun 12. pii: S0016-5085(18)34642.
    >> Share

  311. SHAH SM, Kamboj AK, Cleary SP
    Large Hepatic Mass in an Adolescent Male.
    Gastroenterology. 2018 Jun 5. pii: S0016-5085(18)34607.
    >> Share

    May 2018
  312. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.
    >> Share

  313. LIU T, Yang H, Fan W, Tu J, et al
    Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Gastroenterology. 2018 May 4. pii: S0016-5085(18)34482.
    >> Share

  314. COSTENTIN C, Layese R, Bourcier V, Cagnot C, et al
    Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-time Adjusted Survival of Patients With Compensated Viral Cirrhosis.
    Gastroenterology. 2018 May 2. pii: S0016-5085(18)30488.
    >> Share

  315. CHUNG HH
    The Multiple Modulation of miR-122 in the Attenuation of Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1857.
    >> Share

  316. GUILLAUME M, Bureau C
    Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome?
    Gastroenterology. 2018;154:1569-1571.
    >> Share

  317. WU J, Yang S, Xu K, Ding C, et al
    Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030.
    Gastroenterology. 2018;154:1719-1728.
    >> Share

  318. IBRAHIM M, Mostafa I, Deviere J
    New Developments in Managing Variceal Bleeding.
    Gastroenterology. 2018;154:1964-1969.
    >> Share

  319. CHEN YY, Chen CC
    Progression of an Unusual Primary Liver Tumor.
    Gastroenterology. 2018;154:1590-1591.
    >> Share

    April 2018
  320. CAO P, Yang A, Wang R, Xia X, et al
    Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30481.
    >> Share

  321. EZCURRA I, Fortea JI, Crespo J
    A rare but recognizable cholestatic liver disease.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30484.
    >> Share

  322. CALVARUSO V, Cabibbo G, Cacciola I, Petta S, et al
    Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441.
    >> Share

  323. LEE BP, Mehta N, Platt L, Gurakar A, et al
    Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30442.
    >> Share

  324. FIRL DJ, Sasaki K, Aucejo FN
    Prognosticating the Candidate Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30306.
    >> Share

  325. SCOTT RA, Aithal GP, Francis ST, Irving WL, et al
    Pretreatment Lesions on Magnetic Resonance Imaging in Patients With Hepatitis C Virus Infection Diagnosed With Hepatocellular Carcinoma After Initiating Direct-Acting Antiviral Therapy.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30305.
    >> Share

    Nonalcoholic Fatty Liver Disease in Alcohol Users: An Oxymoron?
    Gastroenterology. 2018;154:1549-1550.
    >> Share

  327. GHOSH G, Shen NT, Jesudian AB
    Coffee Bean Sign With a Twist.
    Gastroenterology. 2018;154:e10-e11.
    >> Share

  328. THIELE M, Madsen BS, Hansen JF, Detlefsen S, et al
    Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1369-1379.
    >> Share

    March 2018
  329. BAI J, Zheng L, Han Y
    Unexpected findings in a patient with hepatomegaly and skin rashes.
    Gastroenterology. 2018 Mar 13. pii: S0016-5085(18)30318.
    >> Share

  330. GRUNVOGEL O, Colasanti O, Lee JY, Kloss V, et al
    Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll Like Receptor 3 in Hepatocytes.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30309.
    >> Share

  331. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    >> Share

  332. CHUNG HH
    New Insights for Controversial Issues of miR-122 in Hepatic Lipid Metabolism.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30146.
    >> Share

  333. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.
    >> Share

  334. BER TI, Ilan Y
    Biomarkers for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30151.
    >> Share

  335. MANDORFER M, Reiberger T, Peck-Radosavljevic M
    Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30150.
    >> Share

  336. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.
    >> Share

  337. HARVEY LD, Chan SY
    YAPping About Glutaminolysis in Hepatic Fibrosis.
    Gastroenterology. 2018 Mar 3. pii: S0016-5085(18)30259.
    >> Share

  338. MCGEOCH LJ, Patel PR, Mann JP
    PNPLA3: A Determinant of Response to Low-Fructose Diet in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;154:1207-1208.
    >> Share

  339. LI G, Liu D, Kimchi ET, Kaifi JT, et al
    Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Gastroenterology. 2018;154:1024-1036.
    >> Share

  340. ANDERSSON ER, Chivukula IV, Hankeova S, Sjoqvist M, et al
    Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
    Gastroenterology. 2018;154:1080-1095.
    >> Share

  341. HOFLAND J, Koch AD, de Herder WW
    Melena in a Patient With a Metastasized Neuroendocrine Tumor.
    Gastroenterology. 2018;154:e6-e7.
    >> Share

    February 2018
  342. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    >> Share

  343. DOU C, Liu Z, Tu K, Zhang H, et al
    P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-promoting Myofibroblasts.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30209.
    >> Share

  344. CHEN C, Soto-Gutierrez A, Baptista PM, Spee B, et al
    Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.
    Gastroenterology. 2018 Feb 8. pii: S0016-5085(18)30166.
    >> Share

  345. TZARTZEVA K, Obi J, Rich NE, Parikh ND, et al
    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30155.
    >> Share

  346. LIVERANI E, Colecchia A, Mazzella G
    Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome.
    Gastroenterology. 2018;154:495-497.
    >> Share

    January 2018
  347. YOSHIKAWA T, Ohana M, Fukuda A
    High fever after radiofrequency ablation of hepatocellular carcinoma.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30134.
    >> Share

  348. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    >> Share

  349. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.
    >> Share

  350. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.
    >> Share

  351. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.
    >> Share

  352. HORVAT N, Ragucci M, Mannelli L
    Hepatic Mass in a Patient With Bladder Cancer History.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)35643.
    >> Share

  353. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.
    >> Share

  354. DU K, Hyun J, Premont RT, Choi SS, et al
    Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Hepatic Stellate Cell Activation.
    Gastroenterology. 2018 Jan 3. pii: S0016-5085(18)30002.
    >> Share

  355. MAURICE JB, Yu D, Watkins J
    A 41-Year-Old Man With Abdominal Pain, Deranged Liver Function, and Fevers.
    Gastroenterology. 2018;154:26-27.
    >> Share

  356. LEE CW, Chen YF, Wu HH, Lee OK, et al
    Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.
    Gastroenterology. 2018;154:46-56.
    >> Share

  357. SATISHCHANDRAN A, Ambade A, Rao S, Hsueh YC, et al
    MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Gastroenterology. 2018;154:238-252.
    >> Share

  358. PIERSON H, Muchenditsi A, Kim BE, Ralle M, et al
    The Function of ATPase Copper Transporter ATP7B in Intestine.
    Gastroenterology. 2018;154:168-180.
    >> Share

    December 2017
  359. WU X, Dao Thi VL, Liu P, Takacs CN, et al
    Pan-Genotype Hepatitis E Virus Replication in Stem Cell-derived Hepatocellular Systems.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36303.
    >> Share

  360. POURCET B, Zecchin M, Ferri L, Beauchamp J, et al
    Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity Of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36725.
    >> Share

  361. ZHANG S, Nguyen LH, Zhou K, Tu HC, et al
    Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice without Affecting Regeneration.
    Gastroenterology. 2017 Dec 20. pii: S0016-5085(17)36717.
    >> Share

    November 2017
    The Role of Transforming Growth Factor-beta in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications from an Integrative Multiomics Approach.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36373.
    >> Share

  363. BI D, Malikowski TM, Sweetser S
    Portal Hypertension and Unexplained Diarrhea in an 80-year-old man.
    Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36339.
    >> Share

  364. KAKAR S, Borhani AA, Malik SM
    A Liver Full of Stars: Hepatostellular!
    Gastroenterology. 2017 Nov 4. pii: S0016-5085(17)35453.
    >> Share

  365. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    >> Share

  366. VANWAGNER LB, Ning H, Allen NB, Ajmera V, et al
    Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;153:1260-1272.
    >> Share

  367. D'MELLO C, Almishri W, Liu H, Swain MG, et al
    Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.
    Gastroenterology. 2017;153:1416-1428.
    >> Share

  368. MOON H, Ju HL, Chung SI, Cho KJ, et al
    Transforming Growth Factor-beta Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Gastroenterology. 2017;153:1378-1391.
    >> Share

    October 2017
  369. MAZZAFERRO V, Sposito C, Zhou J, Pinna AD, et al
    Metroticket 2.0 Model for Analysis of Competing Risks of Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36184.
    >> Share

  370. CAO W, Chen K, Bolkestein M, Yin Y, et al
    Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury.
    Gastroenterology. 2017;153:1133-1147.
    >> Share

  371. HSU EK, Shaffer ML, Gao L, Sonnenday C, et al
    Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Gastroenterology. 2017;153:988-995.
    >> Share

  372. CHEN ZH, Yu YP, Tao J, Liu S, et al
    MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
    Gastroenterology. 2017;153:1120-1132.
    >> Share

    September 2017
  373. ZHANG K, Kim H, Fu Z, Qiu Y, et al
    Deficiency of the Mitochondrial NAD Kinase Causes Stress-induced hepatic steatosis in mice.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36150.
    >> Share

  374. ENGELHOLM LH, Riaz A, Serra D, Dagnaes-Hansen F, et al
    CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36148.
    >> Share

  375. CHEN J, Zaidi S, Rao S, Chen JS, et al
    Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor beta Pathway Short title: Prognostic significance of TGF-beta signature in liver cancer.
    Gastroenterology. 2017 Sep 14. pii: S0016-5085(17)36144.
    >> Share

  376. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.
    >> Share

  377. ESO Y, Mishima M, Fukuda A
    An Unusual Cause of Hepatic Dysfunction.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35460.
    >> Share

    August 2017
  378. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.
    >> Share

  379. CRISMALE JF, Ward SC, Ahmad J
    An Unusual Cause of Abdominal Pain and Biliary Obstruction in a Patient with Hepatocellular Carcinoma.
    Gastroenterology. 2017 Aug 30. pii: S0016-5085(17)36074.
    >> Share

  380. KIM K, Ryu D, Dongiovanni P, Ozcan L, et al
    Degradation of PHLPP2 by KCTD17, via a Glucagon-dependent Pathway, Promotes Hepatic Steatosis.
    Gastroenterology. 2017 Aug 28. pii: S0016-5085(17)36072.
    >> Share

  381. SCHMIDT-MARTIN D, Armstrong MJ, Rowe IA
    Transplant-Free Survival Rates After Covered Transjugular Intrahepatic Portosystemic Shunt.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35885.
    >> Share

  382. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    >> Share

    July 2017
  383. PATEL YA, Imperial J, Muir AJ, Anstee QM, et al
    Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations from the Liver Forum.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35955.
    >> Share

  384. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    >> Share

  385. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    >> Share

  386. KING A, Houlihan DD, Kavanagh D, Haldar D, et al
    Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology. 2017;153:233-248.
    >> Share

  387. KHAMRI W, Abeles RD, Hou TZ, Anderson AE, et al
    Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Gastroenterology. 2017;153:263-276.
    >> Share

    June 2017
  388. ZHOU G, Sprengers D, Boor PPC, Doukas M, et al
    Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-infiltrating T cells in Hepatocellular Carcinomas.
    Gastroenterology. 2017 Jun 22. pii: S0016-5085(17)35802.
    >> Share

  389. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    >> Share

  390. VANCLOOSTER A, van Deursen C, Jaspers R, Cassiman D, et al
    Proton pump inhibitors decrease phlebotomy need in HFE hemochromatosis: double-blind randomized placebo-controlled trial.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35740.
    >> Share

  391. NANO J, Ghanbari M, Wang W, de Vries PS, et al
    Epigenome-wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35737.
    >> Share

  392. SIA D, Jiao Y, Martinez-Quetglas I, Kuchuk O, et al
    Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35741.
    >> Share

  393. MIDDLETON MS, Heba ER, Hooker CA, Bashir MR, et al
    Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-assigned Steatosis Grades of Liver Biopsies from Adults with Nonalcoholic Steatohepatitis.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35739.
    >> Share

  394. JIN B, Du G, Li T
    Right Upper Abdominal Distension and Discomfort Caused by a Massive Hepatic Tumor.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(16)35356.
    >> Share

  395. JIN H, Wang C, Jin G, Ruan H, et al
    Regulator of Calcineurin 1 Gene Isoform 4, Downregulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Growth of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35687.
    >> Share

  396. CANNON MD, Heneghan MA
    Endoscopy in Pregnant Women with Liver Cirrhosis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35602.
    >> Share

  397. WEILER SME, Pinna F, Wolf T, Lutz T, et al
    Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Gastroenterology. 2017;152:2037-2051.
    >> Share

  398. XIMENES RO, Vieira Costa JP, Pereira E Silva KT
    Cullen's sign - not always acute pancreatitis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35650.
    >> Share

    May 2017
  399. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    >> Share

  400. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    >> Share

  401. TAN HK, Leow WQ, Chang PE
    Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(16)35073.
    >> Share

  402. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    >> Share

  403. ROCCARO GA, Goldberg DS
    Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?
    Gastroenterology. 2017 May 3. pii: S0016-5085(17)35551.
    >> Share

  404. ABATE N, Chandalia M
    Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians.
    Gastroenterology. 2017;152:1647-1655.
    >> Share

  405. CAMILLERI M, Malhi H, Acosta A
    Gastrointestinal Complications of Obesity.
    Gastroenterology. 2017;152:1656-1670.
    >> Share

  406. LAI KKY, Kweon SM, Chi F, Hwang E, et al
    Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Gastroenterology. 2017;152:1477-1491.
    >> Share

    April 2017
  407. KALYAN A, Kulik L
    Multi-disciplinary Care in Hepatocellular Carcinoma: Where Do We Go from Here?
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35538.
    >> Share

  408. CUI L, Nakano K, Obchoei S, Setoguchi K, et al
    Small Nucleolar Noncoding RNA SNORA23, Upregulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of SYNE2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35402.
    >> Share

  409. PAN LH, Zhao C, Ma YL
    Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?
    Gastroenterology. 2017 Apr 3. pii: S0016-5085(17)30221.
    >> Share

  410. DURAN R, Deltenre P, Denys A
    RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30224.
    >> Share

  411. NICOLETTI P, Aithal GP, Bjornsson ES, Andrade RJ, et al
    Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Gastroenterology. 2017;152:1078-1089.
    >> Share

  412. AN SY, Jang YJ, Lim HJ, Han J, et al
    Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    Gastroenterology. 2017;152:1174-1186.
    >> Share

  413. SONG CQ, Li Y, Mou H, Moore J, et al
    Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
    Gastroenterology. 2017;152:1161-1173.
    >> Share

    March 2017
  414. YOUNG S, Golzarian J
    Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30225.
    >> Share

  415. GARIN E, Pallard X, Edeline J
    Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30222.
    >> Share

  416. ZHANG W, He H, Zang M, Wu Q, et al
    Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30333.
    >> Share

  417. HOWELL J, Thompson AJ
    Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.
    >> Share

  418. ALVARO D
    Gallstones: bad company for the steatotic liver.
    Gastroenterology. 2017 Mar 25. pii: S0016-5085(17)30329.
    >> Share

  419. DURNO C, Boland CR, Cohen S, Dominitz JA, et al
    Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2017 Mar 22. pii: S0016-5085(17)30175.
    >> Share

  420. SIA D, Villanueva A, Friedman SL, Llovet JM, et al
    Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Gastroenterology. 2017;152:745-761.
    >> Share

  421. HENDIFAR AE, Davies L, Tuli R
    Private Funding for Pancreatic Cancer Research: More Than a Chip Shot.
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30229.
    >> Share

    February 2017
  422. CHAVEZ-TALAVERA O, Tailleux A, Lefebvre P, Staels B, et al
    Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD.
    Gastroenterology. 2017 Feb 15. pii: S0016-5085(17)30157.
    >> Share

  423. PATEL SH, Camargo FD, Yimlamai D
    Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
    Gastroenterology. 2017;152:533-545.
    >> Share

  424. PARK CC, Nguyen P, Hernandez C, Bettencourt R, et al
    Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;152:598-607.
    >> Share

  425. MARKOVA M, Pivovarova O, Hornemann S, Sucher S, et al
    Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Gastroenterology. 2017;152:571-585.
    >> Share

    January 2017
  426. ASAI Y, Yamada T, Tsukita S, Takahashi K, et al
    Activation of the Hypoxia Inducible Factor 1 Alpha Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30012.
    >> Share

  427. WOODEN B, Goossens N, Hoshida Y, Friedman SL, et al
    Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.
    Gastroenterology. 2017;152:53-67.
    >> Share

    December 2016
  428. RICH N, Singal AG
    Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Potential New Challenge for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2016;151:1246-1248.
    >> Share

    October 2016
  429. ZHANG YM, Wang J, Chen DF
    A Rare Cause of Massive Upper Gastrointestinal Bleeding.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)34648.
    >> Share

    TIMPing Fate: Why Pancreatic Cancer Cells Sojourn in the Liver.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35132.
    >> Share

    May 2016
  431. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    >> Share

    Entering the GOLDEN Age for Therapies in NASH.
    Gastroenterology. 2016;150:1073-6.
    >> Share

    February 2016
  433. WANG L, Yin J, Wang X, Shao M, et al
    C-type Lectin-like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of PI3K Subunits.
    Gastroenterology. 2016 Feb 5. pii: S0016-5085(16)00133.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016